However, in specific patient populations—those with elevated triglyceride (TG), diabetes mellitus (DM), obesity, or very low LDL-C concentrations—the assessment of non-high-density lipoprotein cholesterol (non-HDL-C) or apolipoprotein B (apoB) levels is recommended [2]. The gene discussed is APOB; the disease is obesity disorder.